dark side of glp-1 🎙️NEW PODCAST: The GLP-1s Suzy Badaracco, president of Culinary Tides, Inc., explains the health risks associated w/ usage, & how the food industry can best serve this category The dark side of GLP-1s…,

Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and meta-analysis

Eating slowly leads to more pronounced GLP-1, higher satiety, and lower food intake

So right away, keep that in mind

Even though there are no studies or clinical trials that show BPC-157 is safe or effective in humans, some websites related to performance-enhancing drugs advertise that it can be injected or taken orally for bone and joint healing, stomach ulcers, organ damage, and a number of other purposes, including athletic performance enhancement

It can influence pro-inflammatory molecules like interleukin-6 (IL-6) and TNF-alpha, which are linked to prolonged inflammation in injury models